Retevmo can target the specific driver of certain RET-positive advanced or metastatic cancers
Retevmo is a targeted cancer therapy; it is not chemotherapy
Retevmo is a prescription oral therapy that was designed to block the primary driver of tumor growth in RET-positive metastatic non-small cell lung cancer (NSCLC) and advanced thyroid cancers.
We all have something called RET in our bodies, similar to how we have faucets in our homes. When a person has a RET alteration, it’s like that faucet gets stuck in the “on” position, allowing water to spread, just as RET alterations allow cancer to grow. Retevmo acts like a wrench that helps turn the faucet off.
Retevmo may affect both healthy cells and tumor cells, which can result in side effects, some of which can be serious.
There are tests to determine if your cancer is driven by a RET alteration.
Click here for tips on how to talk to your doctor about getting tested for RET and to find out if Retevmo is right for you.
SELECT SAFETY INFORMATION
High blood pressure (hypertension): High blood pressure is common with RETEVMO and may sometimes be serious. You should check your blood pressure regularly during treatment with RETEVMO. Tell your doctor if you get any of the following symptoms:
- shortness of breath
- chest pain
See how Retevmo may help people living with RET-positive metastatic NSCLC.
See how Retevmo may help people living with RET-positive advanced thyroid cancer.